Future Price to Earnings: carmellcosmetics.com (XAGE)

Symbol and logo of brand Carmell Therapeutics (XAGE)

The consensus forward P/E of Longevity Health Holdings (XAGE) correlates with the performance of its staff of regenerative physicians and biologists, while the 0.00 level indicates the state of the parameter. The business foundation relies on the moderate development of R&D in the field of plasma biomaterials. However, strict oversight of cosmetic components and brand promotion costs following the asset merger hinder stability.

Carmell Therapeutics - XAGE Market Cap to Future Earnings Ratio (period 03/11/2025 - 09/27/2025)

Summary analytical data breakdowns for carmellcosmetics.com (XAGE)

- company stock exchange capitalization indicators:
Summary company analytics:Carmell Therapeutics Corporation
Signature product of Longevity Health Holdings

Forward P/E reflects the ratio of the current quote to projected earnings, allowing investors to assess the premium paid for future business growth rates. Within the GURU.Markets system, the issuer's expected P/E helps correlate the market value of Longevity Health Holdings (XAGE) with the efficiency of automated protein synthesis, where scaling production without increasing headcount should optimize margins, as clearly illustrated on this chart.

Competitor analysis

Future Price to Earnings HCA Holdings (HCA)|Tenet Healthcare - Price to Future Earnings Ratio|Fresenius Medical Care Corp - Projected Price to Earnings|SOLV: Price to Future Earnings Ratio|Encompass - Forward P/E Multiple|UHS - Forward P/E Multiple|DVA: Forward P/E Multiple|RadNet Corp - Future Price to Earnings Multiple|Future Price to Earnings Option Care Health Inc|Forward P/E Multiple surgerypartners.com|Forward P/E Multiple PINC|Market Cap to Projected Earnings National Vision Holdings, Inc.|Forward P/E Multiple PGNY (Progyny Inc)|Ardent Health Corp (ARDT) - Projected Price to Earnings Ratio|SEM: Projected Price to Earnings|ASTH - Forward P/E Multiple|MD: Forward P/E Multiple|Price to Expected Earnings Ratio USPH (US Physical Therapy)|Future Price to Earnings The Pennant Group, Inc.|ORGO - Forward Price to Earnings Multiple|Forward P/E Multiple NUTX|Forward P/E Multiple Auna (AUNA)|Forward P/E Multiple SBC (sbc-holdings.com)|EOLS: Price to Future Earnings Ratio|Community Health Systems Inc - Forward P/E Multiple|Projected Price to Earnings Ratio The Beauty Health Company|MediWound Ltd (MDWD) - Future Price to Earnings|BTMD - Market Cap to Projected Earnings|Future Price to Earnings The Joint|Projected Price to Earnings DocGo (DCGO)|P3 Health Partners, Inc. (PIII) - Future Price to Earnings Multiple|Forward P/E Multiple Gain Therapeutics (GANX)|Forward P/E Multiple EUDA (EUDA Health)|Future Price to Earnings Multiple BMGL|CollPlant Ltd - Forward P/E Multiple|Forward Price to Earnings Multiple Cuprina Holdings (Cayman) Ltd. (CUPR)|Concord Medical Corp (CCM) - Future Price to Earnings|ASHS - Future Price to Earnings Multiple|Future Price to Earnings MEDIROM Healthcare Group|Forward P/E Multiple avalon-globocare.com|Forward P/E Multiple DHAI|Market Cap to Projected Earnings NewGenIvf Group|Future Price to Earnings ATI Physical Therapy Inc. ATIP|CareMax Medical Group (CMAX) - Projected Price to Earnings Ratio|KDLY - Future Price to Earnings|Future Price to Earnings Multiple MODV (ModivCare Inc.)|Novo Integrated (NVOS) - Future Price to Earnings|SSY - Market Cap to Projected Earnings|Future Price to Earnings IMAC Holdings Inc